After surpassing Q2 financial expectations, reporting $11.1 million in revenue, Bloom Health Partners (CSE: BLMH) is on track to smash its yearly guidance.
In a recent interview, CEO Andre Morton stated the company is executing the plan it has promised investors. $BLMH.c has provided guidance of $25-$28 million in revenue for this year, which would take its SP to well over $1 based on its P/E ratio at the beginning of this year.
Additionally, $BLMH recently closed the first tranche of its private placement for proceeds of $1,030,000. The net proceeds will be put towards ongoing working capital expenses and corporate development.
$BLMH.c is currently trading at $.21, valued at $8.2 million.
https://ceo.ca/@newsfile/bloom-health-partners-announces-closing-of-first-tranche